These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

567 related items for PubMed ID: 14960504

  • 1. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).
    Marre M, Lievre M, Chatellier G, Mann JF, Passa P, Ménard J, DIABHYCAR Study Investigators.
    BMJ; 2004 Feb 28; 328(7438):495. PubMed ID: 14960504
    [Abstract] [Full Text] [Related]

  • 2. Assessment of patients' and physicians' compliance to an ACE inhibitor treatment based on urinary N-acetyl Ser-Asp-Lys-Pro determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) study.
    Azizi M, Ménard J, Peyrard S, Lièvre M, Marre M, Chatellier G.
    Diabetes Care; 2006 Jun 28; 29(6):1331-6. PubMed ID: 16732017
    [Abstract] [Full Text] [Related]

  • 3. Determinants of elevated urinary albumin in the 4,937 type 2 diabetic subjects recruited for the DIABHYCAR Study in Western Europe and North Africa.
    Marre M, Lièvre M, Vasmant D, Gallois Y, Hadjadj S, Reglier JC, Chatellier G, Mann J, Viberti GC, Passa P.
    Diabetes Care; 2000 Apr 28; 23 Suppl 2():B40-8. PubMed ID: 10860190
    [Abstract] [Full Text] [Related]

  • 4. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
    Dalla Vestra M, Pozza G, Mosca A, Grazioli V, Lapolla A, Fioretto P, Crepaldi G.
    Diabetes Nutr Metab; 2004 Oct 28; 17(5):259-66. PubMed ID: 16295047
    [Abstract] [Full Text] [Related]

  • 5. Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease.
    Song JH, Cha SH, Lee HJ, Lee SW, Park GH, Lee SW, Kim MJ.
    Nephrol Dial Transplant; 2006 Mar 28; 21(3):683-9. PubMed ID: 16330466
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The HOPE Study (Heart Outcomes Prevention Evaluation).
    Sleight P.
    J Renin Angiotensin Aldosterone Syst; 2000 Mar 28; 1(1):18-20. PubMed ID: 11967789
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diabetes and the HOPE study: implications for macrovascular and microvascular disease.
    Gerstein HC.
    Int J Clin Pract Suppl; 2001 Jan 28; (117):8-12. PubMed ID: 11715357
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
    Ravid M, Lang R, Rachmani R, Lishner M.
    Arch Intern Med; 1996 Feb 12; 156(3):286-9. PubMed ID: 8572838
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency.
    Tong PC, Ko GT, Chan WB, Ma RC, So WY, Lo MK, Lee KF, Ozaki R, Chow CC, Cockram CS, Chan JC.
    Diabetes Obes Metab; 2006 May 12; 8(3):342-7. PubMed ID: 16634995
    [Abstract] [Full Text] [Related]

  • 14. [Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy].
    Parving HH, Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S.
    Ugeskr Laeger; 2001 Oct 01; 163(40):5514-9. PubMed ID: 11601117
    [Abstract] [Full Text] [Related]

  • 15. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*.
    Schrader J, Lüders S, Kulschewski A, Hammersen F, Züchner C, Venneklaas U, Schrandt G, Schnieders M, Rangoonwala B, Berger J, Dominiak P, Zidek W, MARPLE Study Group.
    J Hypertens; 2006 Mar 01; 24(3):541-8. PubMed ID: 16467658
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies.
    Tobe SW, Clase CM, Gao P, McQueen M, Grosshennig A, Wang X, Teo KK, Yusuf S, Mann JF, ONTARGET and TRANSCEND Investigators.
    Circulation; 2011 Mar 15; 123(10):1098-107. PubMed ID: 21357827
    [Abstract] [Full Text] [Related]

  • 17. Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria.
    Heerspink HL, Greene T, Lewis JB, Raz I, Rohde RD, Hunsicker LG, Schwartz SL, Aronoff S, Katz MA, Eisner GM, Mersey JH, Wiegmann TB, Collaborative Study Group.
    Nephrol Dial Transplant; 2008 Jun 15; 23(6):1946-54. PubMed ID: 18089623
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of efficacy and tolerability of Losartan and Ramipril combination in the management of hypertensive patients with associated diabetes mellitus in India (LORD Trial).
    Joshi SR, Yeolekar ME, Tripathi KK, Giri J, Maity AK, Chopda M, Gujarathi S, Maroli S, Maity A, LORD Trial.
    J Assoc Physicians India; 2004 Mar 15; 52():189-95. PubMed ID: 15636307
    [Abstract] [Full Text] [Related]

  • 19. Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function.
    van den Meiracker AH, Baggen RG, Pauli S, Lindemans A, Vulto AG, Poldermans D, Boomsma F.
    J Hypertens; 2006 Nov 15; 24(11):2285-92. PubMed ID: 17053552
    [Abstract] [Full Text] [Related]

  • 20. Strict blood-pressure control and progression of renal failure in children.
    ESCAPE Trial Group, Wühl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, Möller K, Wigger M, Peruzzi L, Mehls O, Schaefer F.
    N Engl J Med; 2009 Oct 22; 361(17):1639-50. PubMed ID: 19846849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.